Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Sareban Nazanin |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2023

Originalarbeit (Zeitschrift)

** Buchta, C; Springer, D; Jovanovic, J; Borsodi, C; Weidner, L; Sareban, N; Radler, U; Muller, MM; Griesmacher, A; Puchhammer-Stockl, E; Wagner, T; Jungbauer, C; Stiasny, K; Weseslindtner, L Three rounds of a national external quality assessment reveal a link between disharmonic anti-SARS-CoV-2 antibody quantifications and the infection stage
CLIN CHEM LAB MED. 2023; Doi: 10.1515/cclm-2022-1161
Web of Science PubMed FullText FullText_MUG

 

** Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
Microbes Infect. 2023; 25(4):105103 Doi: 10.1016/j.micinf.2023.105103 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Smolle, MA; Helmberg, W; Matzhold, EM; Barth, DA; Sareban, N; Szkandera, J; Liegl-Atzwanger, B; Leithner, A; Pichler, M Impact of allogeneic red blood cell transfusion on prognosis in soft tissue sarcoma patients. A single-centre study.
Cancer Med. 2023; 12(2):1237-1246 Doi: 10.1002/cam4.4989 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Sourij, C; Aziz, F; Kojzar, H; Obermayer, AM; Sternad, C; Müller, A; Tripolt, NJ; Pferschy, PN; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Steinmetz, I; Sourij, H Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2023; 25(1): 314-318. Doi: 10.1111/dom.14855 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Originalarbeit (Zeitschrift)

** Sourij, C; Tripolt, NJ; Aziz, F; Aberer, F; Forstner, P; Obermayer, AM; Kojzar, H; Kleinhappl, B; Pferschy, PN; Mader, JK; Cvirn, G; Goswami, N; Wachsmuth, N; Eckstein, ML; Müller, A; Abbas, F; Lenz, J; Steinberger, M; Knoll, L; Krause, R; Stradner, M; Schlenke, P; Sareban, N; Prietl, B; Kaser, S; Moser, O; Steinmetz, I; Sourij, H, , COVAC-DM, study, group Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2022; 24(5):849-858 Doi: 10.1111/dom.14643 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Sourij, C; Aziz, F; Kojzar, H; Obermayer, A; Sternad, C; Forstner, P; Muller, A; Tripolt, N; Pferschy, P; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Sourij, H SARS-CoV-2S antibody formation is not impaired in people with type 1 or type 2 diabetes, but the antibody level falls more rapidly in this collective - the -COVAC-DM study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):259-260. [Oral Communication]
Web of Science

 

2021

Originalarbeit (Zeitschrift)

** Barth, DA; Sareban, N; Lindner, AK; Daller, LAJ; Matzhold, EM; Hutterer, G; Smolle, M; Mischinger, J; Riedl, JM; Seles, M; Mannweiler, S; Bauernhofer, T; Pummer, K; Pichler, R; Zigeuner, R; Schlenke, P; Pichler, M Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Urol Oncol. 2021; 39(10):736.e9-736.e16 Doi: 10.1016/j.urolonc.2021.06.005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Posch, F; Sareban, N; Stradner, M; Rosskopf, K; Reisinger, AC; Eller, P; Schörghuber, M; Toller, W; Sloup, Z; Prüller, F; Gütl, K; Pilz, S; Rosenkranz, AR; Greinix, HT; Krause, R; Schlenke, P; Schilcher, G Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study.
Ann Intensive Care. 2021; 11(1): 73 Doi: 10.1186/s13613-021-00867-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schulz, E; Hodl, I; Forstner, P; Hatzl, S; Sareban, N; Moritz, M; Fessler, J; Dreo, B; Uhl, B; Url, C; Grisold, AJ; Khalil, M; Kleinhappl, B; Enzinger, C; Stradner, MH; Greinix, HT; Schlenke, P; Steinmetz, I CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.
Front Immunol. 2021; 12:803742 Doi: 10.3389/fimmu.2021.803742 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fallbericht

** Guetl, K; Moazedi-Fuerst, F; Rosskopf, K; Brodmann, M; Krause, R; Eller, P; Wilhelmer, P; Eisner, F; Sareban, N; Schlenke, P; Kessler, HH; Steinmetz, I; Redlberger-Fritz, M; Stiasny, K; Stradner, M SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia.
J Infect. 2021; 82(3):414-451 Doi: 10.1016/j.jinf.2020.10.025 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kommentar

** Kral, S; Banfi, C; Niedrist, T; Sareban, N; Guelly, C; Kriegl, L; Schiffmann, S; Zurl, C; Herrmann, M; Steinmetz, I; Schlenke, P; Berghold, A; Krause, R Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study.
J Infect. 2021; 83(5): 607-635. Doi: 10.1016/j.jinf.2021.08.030 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Originalarbeit (Zeitschrift)

** Macher, S; Drexler, C; Lindenau, I; Sareban, N; Schlenke, P; Amrein, K High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial.
Trials. 2016; 17(1):527-527 Doi: 10.1186/s13063-016-1648-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Originalarbeit (Zeitschrift)

** Sareban, N; Macher, S; Drexler, C; Posch, U; Lanzer, G; Schallmoser, K Platelet antibody analysis by three different tests.
J Clin Lab Anal. 2015; 29(3):198-202 Doi: 10.1002/jcla.21750 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Macher, S; Drexler, C; Stojakovic, T; Lindenau, I; Schrock, M; Reinprecht, C; Sareban, N; Amrein, K INTRAVENOUS HIGH-DOSE IRON SUPPLEMENTATION FOR BLOOD DONORS WITH IRON DEFICIENCY
HAEMATOLOGICA. 2015; 100: 140-140.-20th Congress of European-Hematology-Association; JUN 11-14, 2015; Vienna, AUSTRIA. [Poster]
Web of Science

 

2012

Abstract (Zeitschrift)

** Macher, S; Sareban, N; Drexler, C; Lanzer, G; Schallmoser, K; Single Center Experience with the Nanoparticle-Based Flow Immunoassay for Diagnosis of Heparin-Induced Thrombocytopenia (HIT).
BLOOD. BLOOD120: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012) Doi: 10.1182/blood.V120.21.2189.2189 [Poster]
Web of Science FullText FullText_MUG

 

© Med Uni Graz Impressum